Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function.
Khachigian
L M
LM
Centre for Thrombosis and Vascular Research, School of Pathology, The University of New South Wales, Sydney, Australia. L.Khachigian@unsw.edu.au
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy*; D002384:Catalysis; D021881:DNA, Catalytic / Q000378:metabolism*; D004277:DNA, Single-Stranded / Q000378:metabolism*; D004268:DNA-Binding Proteins / Q000378:metabolism*; D051766:Early Growth Response Protein 1; D006801:Humans; D017874:Immediate-Early Proteins / Q000378:metabolism*; D016376:Oligonucleotides, Antisense; D016337:RNA, Catalytic; D014157:Transcription Factors / Q000378:metabolism*
C400152:DNA enzyme ED5; D021881:DNA, Catalytic; D004277:DNA, Single-Stranded; D004268:DNA-Binding Proteins; C497325:EGR1 protein, human; D051766:Early Growth Response Protein 1; D017874:Immediate-Early Proteins; D016376:Oligonucleotides, Antisense; D016337:RNA, Catalytic; D014157:Transcription Factors